Mubadala invests in Indian company Manibal

Today, investment company Mubadala announced its investment in the Indian company Manipal Health Enterprises, also known as “Manipal”.

Singapore-based global investment company Temasek will continue to hold the majority share in Manipal.

Manibal provides high-quality healthcare services at affordable prices through a multi-specialty care network. Currently, they serve around 6 million patients annually through over 30 hospitals located across India.

Manibal is the second-largest hospital chain in India in terms of bed capacity and employs over 5,000 doctors.

Camilla Macabelli, Head of the Life Sciences Unit at Mubadala, said on this occasion: “Manipal, one of the leading healthcare networks in India, stands out for its commitment to clinical excellence and institutional governance standards, as well as its exceptional patient care.

We look forward to supporting Manipal in its growth journey in the coming years, benefiting from the increasing demand for high-quality medical care services across India.”

From his side, Luca Molinari, the head of direct investments unit in Asia at Mubadala Company, said: “We are pleased to work with distinguished partners like Temasek, TPJ, Dr. Rangan Bai, and the executive team in Manibal to develop our business in the next phase of growth.”

He added: “Manibal plays a pivotal role in the development of healthcare infrastructure in India, and we are pleased to collaborate with them.”

It is worth mentioning that Maniball was established in 1991 by Dr. Rangan Pai, starting in the city of Bangalore before rapidly expanding its activities to cover the entire country.